Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.

Autor: Aleshina OA; National Medical Research Center for Hematology, Moscow, Russia. Electronic address: dr.gavrilina@mail.ru., Zakurdaeva K; RakFond, Moscow, Russia., Vasileva AN; National Medical Research Center for Hematology, Moscow, Russia., Dubov SK; Regional Clinical Hospital #2, Vladivostok, Russia., Dubov VS; Regional Clinical Hospital #2, Vladivostok, Russia., Vorobyev VI; Regional Clinical Hospital, Saint-Petersburg, Russia., Butaev LS; S.P. Botkin City Clinical Hospital, Moscow, Russia., Sukhareva AM; S.P. Botkin City Clinical Hospital, Moscow, Russia., Gavrilova LV; Republican Clinical Hospital #4, Saransk, Russia., Toropova IY; Regional Clinical Hospital, Yaroslavl, Russia., Popova MO; R.M. Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russia., Siniaev AA; R.M. Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russia., Kulagin AD; R.M. Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russia., Kaplanov KD; S.P. Botkin City Clinical Hospital, Moscow, Russia., Petrenko AA; S.P. Botkin City Clinical Hospital, Moscow, Russia., Ochirova OI; N.A. Semashko Republican Clinical Hospital, Ulan-Ude, Russia., Karpova A; N.A. Semashko Republican Clinical Hospital, Ulan-Ude, Russia., Chelysheva EY; National Medical Research Center for Hematology, Moscow, Russia., Turkina AG; National Medical Research Center for Hematology, Moscow, Russia., Gurianova MA; National Medical Research Center for Hematology, Moscow, Russia., Al-Radi LS; National Medical Research Center for Hematology, Moscow, Russia., Gilyazitdinova EA; National Medical Research Center for Hematology, Moscow, Russia., Egorova EK; National Medical Research Center for Hematology, Moscow, Russia., Chabaeva YA; National Medical Research Center for Hematology, Moscow, Russia., Kulikov SM; National Medical Research Center for Hematology, Moscow, Russia., Sveshnikova YV; Regional Clinical Hospital, Yekaterinburg, Russia., Kunst MA; Republican Clinical Hospital of Tatarstan, Kazan, Russia., Shuvaev V; Research Institute of Hematology and Transfusiology, Saint-Petersburg, Russia., Rakhmani AF; S.P. Botkin City Clinical Hospital, Moscow, Russia., Panteleeva OL; Regional Clinical Hospital, Vladimir, Russia., Grishunina ME; N.A. Semashko Regional Clinical Hospital, Nizhniy Novgorod, Russia., Samoylova OS; N.A. Semashko Regional Clinical Hospital, Nizhniy Novgorod, Russia., Vorontsova E; Regional Clinical Hospital, Novosibirsk, Russia., Baryshnikova DV; Regional Clinical Hospital, Omsk, Russia., Parovichnikova EN; National Medical Research Center for Hematology, Moscow, Russia.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Aug; Vol. 23 (8), pp. 589-598. Date of Electronic Publication: 2023 Apr 14.

[The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description].

Autor: Melikyan AL; National Research Center for Hematology., Subortseva IN; National Research Center for Hematology., Gilyazitdinova EA; National Research Center for Hematology., Koloshejnova TI; National Research Center for Hematology., Egorova EK; National Research Center for Hematology., Pustovaya EI; National Research Center for Hematology., Sudarikov AB; National Research Center for Hematology., Abdullaev AO; National Research Center for Hematology., Gorgidze LA; National Research Center for Hematology., Chebotarev DI; National Research Center for Hematology.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2020 Sep 01; Vol. 92 (7), pp. 95-99. Date of Electronic Publication: 2020 Sep 01.

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.

Autor: Melikyan AL; National Research Center for hematology, Moscow, Russia., Subortseva IN; National Research Center for hematology, Moscow, Russia., Gilyazitdinova EA; National Research Center for hematology, Moscow, Russia., Koloshejnova TI; National Research Center for hematology, Moscow, Russia., Pustovaya EI; National Research Center for hematology, Moscow, Russia., Egorova EK; National Research Center for hematology, Moscow, Russia., Kovrigina AM; National Research Center for hematology, Moscow, Russia., Sudarikov AB; National Research Center for hematology, Moscow, Russia., Abdullaev AO; National Research Center for hematology, Moscow, Russia., Lomaia EG; Almazov National Medical Research Center, Saint Petersburg, Russia., Siordiya NT; Almazov National Medical Research Center, Saint Petersburg, Russia., Zaritskey AY; Almazov National Medical Research Center, Saint Petersburg, Russia., Savchenko VG; National Research Center for hematology, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2018 Aug 17; Vol. 90 (7), pp. 23-29.

[Clinical and morphological features of different types of Castleman's disease].

Autor: Melikyan AL; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Egorova EK; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Kovrigina АМ; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Subortseva IN; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Gilyazitdinova EA; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Karagyulyan SR; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Silaev MA; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Gemdzhian EG; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Savchenko VG; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (7), pp. 64-71.